August 21, 2014: Analysts and unnamed sources continue to speculate on potential targets for U.S. pharmaceutical company Pfizer to acquire. As reported in early August, Berenberg Bank speculated that Pfizer might bid on UK-based GlaxoSmithKline.
August 21, 2014: Several companies, including Mylan, have submitted a second round of bidding for a portfolio of older GlaxoSmithKline drugs. The portfolio includes antidepressant Paxil, antimalarial Malarone, and fish-oil based Lovaza.
August 21, 2014: Auxilium Pharmaceuticals announced positive results today in a randomized, double-blind Phase 2a study of collagenase clostridium histolyticum.
August 21, 2014: Mark Ahn, CEO of Galena Biopharma was forced to resign. Ahn is to be replaced by Mark W. Schwartz, who will be CEO, effective immediately.